In Silico Vaccine Design Based on Molecular Simulations of Rhinovirus Chimeras Presenting HIV-1 gp41 Epitopes

被引:32
作者
Lapelosa, Mauro [1 ,2 ,3 ]
Gallicchio, Emilio [1 ,2 ]
Arnold, Gail Ferstandig [2 ,3 ]
Arnold, Eddy [2 ,3 ]
Levy, Ronald M. [1 ,2 ]
机构
[1] Rutgers State Univ, BioMaPS Inst Quantitat Biol, Piscataway, NJ 08854 USA
[2] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA
[3] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA
基金
美国国家卫生研究院;
关键词
vaccine design; monoclonal antibody 2F5; replica exchange method; chimeric virus; VIRUS TYPE-1 ENVELOPE; PROXIMAL EXTERNAL REGION; IMPLICIT SOLVENT MODEL; COMMON COLD VIRUS; ANTIBODY; 2F5; NEUTRALIZING ANTIBODIES; FORCE-FIELD; GLYCOPROTEIN; PEPTIDE; LOOP;
D O I
10.1016/j.jmb.2008.10.089
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A cluster of promising epitopes for the development of human immunodeficiency virus (HIV) vaccines is located in the membrane-proximal external region (MPER) of the gp41 subunit of the HIV envelope spike structure. The crystal structure of the peptide corresponding to the so-called ELDKWA epitope (HIV-1 HxB2 gp41 residues 662-668), in complex with the corresponding broadly neutralizing human monoclonal antibody 2F5, provides a target for structure-based vaccine design strategies aimed at finding macromolecular carriers that are able to present this MPER-derived epitope with optimal antigenic activity. To this end, a series of replica exchange molecular dynamics computer simulations was conducted to characterize the distributions of conformations of ELDKWA-based epitopes inserted into a rhinovirus carrier and to identify those with the highest fraction of conformations that are able to bind 2F5. The length, hydrophobic character, and precise site of insertion were found to be critical for achieving structural similarity to the target crystal structure. A construct with a high degree of complementarity to the corresponding determinant region of 2175 was obtained. This construct was employed to build a high-resolution structural model of the complex between the 2175 antibody and the chimeric human rhinovirus type 14:HIV-1 ELDKWA virus particle. Additional simulations, which were conducted to study the conformational propensities of the ELDKWA region in solution, confirm the hypothesis that the ELDKWA region of gp41 is highly flexible and capable of assuming helical conformations (as in the postfusion helical bundle structure) and beta-turn conformations (as in the complex with the 2F5 antibody). These results also suggest that the ELDKWA epitope can be involved in intramolecular-and likely intermolecular-hydrophobic interactions. This tendency offers an explanation for the observation that mutations decreasing the hydrophobic character of the MPER in many cases result in conformational changes that increase the affinity of this region for the 2175 antibody. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:675 / 691
页数:17
相关论文
共 50 条
  • [41] Role for the Terminal Clasp of HIV-1 gp41 Glycoprotein in the Initiation of Membrane Fusion
    Lay, Chan-Sien
    Ludlow, Louise E.
    Stapleton, David
    Bellamy-McIntyre, Anna K.
    Ramsland, Paul A.
    Drummer, Heidi E.
    Poumbourios, Pantelis
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (48) : 41331 - 41343
  • [42] Design of hydrophilic, helical peptides that mimic the 4E10 epitope of HIV-1 gp41
    Lorenz, I. C.
    Martin, C. L.
    Hoffenberg, S.
    Phogat, S. K.
    Kaminsky, S. M.
    RETROVIROLOGY, 2009, 6
  • [43] Development of a DNA vaccine expressing a secreted HIV-1 gp41 ectodomain that includes the membrane-proximal external region
    Melnychuk, Luca
    Ajamian, Lara
    Jean-Pierre, Patrick
    Liang, Jiaming
    Gheorghe, Romina
    Wainberg, Mark A.
    Zaharatos, Gerasimos J.
    VACCINE, 2017, 35 (20) : 2736 - 2744
  • [44] Topological analysis of the gp41 MPER on lipid bilayers relevant to the metastable HIV-1 envelope prefusion state
    Wang, Yi
    Kaur, Pavanjeet
    Sun, Zhen-Yu J.
    Elbahnasawy, Mostafa A.
    Hayati, Zahra
    Qiao, Zhi-Song
    Bui, Nhat N.
    Chile, Camila
    Nasr, Mahmoud L.
    Wagner, Gerhard
    Wang, Jia-Huai
    Song, Likai
    Reinherz, Ellis L.
    Kim, Mikyung
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (45) : 22556 - 22566
  • [45] Progress towards the development of a HIV-1 gp41-directed vaccine
    McGaughey, GB
    Barbato, G
    Bianchi, E
    Freidinger, RM
    Garsky, VM
    Hurni, WM
    Joyce, JG
    Liang, XP
    Miller, MD
    Pessi, A
    Shiver, JW
    Bogusky, MJ
    CURRENT HIV RESEARCH, 2004, 2 (02) : 193 - 204
  • [46] Targeting HIV-1 gp41 in Close Proximity to the Membrane Using Antibody and Other Molecules
    Gach, Johannes S.
    Leaman, Daniel P.
    Zwick, Michael B.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (24) : 2997 - 3021
  • [47] Evaluation of a synthetic C34 trimer of HIV-1 gp41 as AIDS vaccines
    Hashimoto, Chie
    Nomura, Wataru
    Ohya, Aki
    Urano, Emiko
    Miyauchi, Kosuke
    Narumi, Tetsuo
    Aikawa, Haruo
    Komano, Jun A.
    Yamamoto, Naoki
    Tamamura, Hirokazu
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (10) : 3287 - 3291
  • [48] Vaccine focusing to cross-subtype HIV-1 gp120 variable loop epitopes
    Cardozo, Timothy
    Wang, Shixia
    Jiang, Xunqing
    Kong, Xiang-Peng
    Hioe, Catarina
    Krachmarov, Chavdar
    VACCINE, 2014, 32 (39) : 4916 - 4924
  • [49] Membrane-transferring sequences of the HIV-1 gp41 ectodomain assemble into an immunogenic complex
    Lorizate, Maier
    Gomara, Maria J.
    de la Torre, Beatriz G.
    Andreu, David
    Nieva, Jose L.
    JOURNAL OF MOLECULAR BIOLOGY, 2006, 360 (01) : 45 - 55
  • [50] Antigenic and immunosuppressive properties of a trimeric recombinant transmembrane envelope protein gp41 of HIV-1
    Muehle, Michael
    Lehmann, Melissa
    Hoffmann, Kerstin
    Stern, Daniel
    Kroniger, Tobias
    Luttmann, Werner
    Denner, Joachim
    PLOS ONE, 2017, 12 (03):